Shaperon Inc

XKRX:378800 (Korea (the Republic of))   Ordinary Shares
â‚© 3875.00 (-12.53%) Oct 18
At Loss
P/B:
5.12
Market Cap:
â‚© 116.80B ($ 85.26M)
Enterprise V:
â‚© 93.38B ($ 68.16M)
Volume:
3.13M
Avg Vol (2M):
9.68M
Trade In:
Volume:
3.13M
At Loss

Business Description

Description
Shaperon Inc is a developer of innovative inflammasome inhibitors and nanobody therapeutics intended to develop novel treatments for various chronic inflammatory diseases, including atopic dermatitis, systemic inflammatory response syndrome, neuroinflammatory diseases, and chronic inflammation. It offers a range of drug candidates, including a gel-type atopic dermatitis drug for use in the treatment of systemic inflammatory response syndrome, neuroinflammatory diseases and for treating chronic inflammation. The company also provides immunotherapeutic products and a single-domain neutralizing antibody, enabling clients to improve patient's quality of life by developing safe and efficacious drugs and immunotherapies.
Name Current Vs Industry Vs History
Cash-To-Debt 67.69
Equity-to-Asset 0.83
Debt-to-Equity 0.02
Debt-to-EBITDA -0.03
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.33
Distress
Grey
Safe
Beneish M-Score -3.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 44.4
3-Year EPS without NRI Growth Rate 43.3
3-Year FCF Growth Rate 0.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.85
9-Day RSI 46.56
14-Day RSI 51.6
6-1 Month Momentum % 25.7
12-1 Month Momentum % -23.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.49
Quick Ratio 13.43
Cash Ratio 13.22

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37.3
Shareholder Yield % -0.13

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -17178.76
Net Margin % -16819
FCF Margin % -17637.73
ROE % -72.9
ROA % -59.12
ROIC % -411.07
ROC (Joel Greenblatt) % -628.97
ROCE % -63.97
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Shaperon Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 91.238
EPS (TTM) (â‚©) -657
Beta 0
Volatility % 109.01
14-Day RSI 51.6
14-Day ATR (â‚©) 471.489293
20-Day SMA (â‚©) 4053
12-1 Month Momentum % -23.77
52-Week Range (â‚©) 1389 - 5150
Shares Outstanding (Mil) 30.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Shaperon Inc Filings

Filing Date Document Date Form
No Filing Data

Shaperon Inc Stock Events

Financials Calendars
Event Date Price(â‚©)
No Event Data

Shaperon Inc Frequently Asked Questions

What is Shaperon Inc(XKRX:378800)'s stock price today?
The current price of XKRX:378800 is â‚©3875.00. The 52 week high of XKRX:378800 is â‚©5150.00 and 52 week low is â‚©1389.00.
When is next earnings date of Shaperon Inc(XKRX:378800)?
The next earnings date of Shaperon Inc(XKRX:378800) is .
Does Shaperon Inc(XKRX:378800) pay dividends? If so, how much?
Shaperon Inc(XKRX:378800) does not pay dividend.

Press Release

Subject Date
No Press Release